A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)
Clinical trial NCT03921411 · COMPLETED
Trial details
- NCT number
- NCT03921411
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-09
- Primary completion
- 2020-08-19
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.